FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3032022111> ?p ?o ?g. }

• W3032022111 endingPage "248" @default.
• W3032022111 startingPage "245" @default.
• W3032022111 abstract "Objective To investigate the clinical efficiency,safety,adverse reactions and healthrelated life quality of transdermal fentanyl patches for pain management in terminal cancer patients with hepatic and renal dysfunction and ascites.Methods 98 terminal cancer patients with moderate to serve pain combined with abnormal hepatic and renal dysfunction were randomly divided into two groups.Group Ⅰ (n=56)received transdermal fentany patches.Group Ⅱ,the control group (n=42),received morphine controlledrelease tablets.Terms of pain intensity,function of renal and liver,adverse reactions and heath-related quality of life were assessed before and after treatment.Results Patients were satisfied with their pain management in both groups,and no significant difference in pain release was observed between the groups (x2 =0.01,0.07,0.01,0.04,P ＞ 0.05).The incidences of constipation and dysuresia were significantly less in the group Ⅰ compared with that of the group Ⅱ (x2 =7.32,3.96,P ＜ 0.05).The incidences of hypersomnia,dizzy,nausea and vomiting were similar betwecn the two groups (x2 =0.12,0.54,0.54,0.02,P ＞ 0.05).Most of the adverse reactions would relieve or disappear after symptomatic treatment.Values of BUN,CR,ALT,AST were similar before and after treatment in group Ⅰ (t =1.43,1.67,0.91,0.11,P＞ 0.05).However,in group Ⅱ,these values were significantly increased after treatment (t =17.59,49.17,42.12,36.23,P ＜ 0.05).The heathrelated life quality (appetite,spirit,somnus,fatigue,daily life and countenance) were significantly improved after treatment in both groups (the group Ⅰ t =3.37,4.40,2.07,5.66,4.48,P ＜ 0.05; the group Ⅱ t =2.03,2.27,3.59,4.16,2.79,P ＜ 0.05),the spirit group Ⅰ improved more obviously compared with group Ⅱ (t =2.93,P ＜ 0.05).Conclusion Transdermal fentanyl patches provides equal pain relief compared with Morphine controlled-release tablets in the terminal cancer patients with abnormal hepatic and renal function and ascites.Transdermal fentanyl patches significantly improve health-related quality with less hepatic and renal function influence and low incidence of adverse reaction.It should be recommended in the treatment terminal cancer patients with moderate to serve pain combined with abnormal hepatic and renal function and ascites.Key words: Transdermal fentanyl patches;  Hepatic insufficiency;  Renal insufficiency;  Ascites" @default.
• W3032022111 created "2020-06-05" @default.
• W3032022111 creator A5066415651 @default.
• W3032022111 date "2013-04-28" @default.
• W3032022111 modified "2023-09-23" @default.
• W3032022111 title "Clinical analysis of transdermal fentanyl patches for pain management in the terminal cancer patients with abnormal hepatic and renal function and ascites" @default.
• W3032022111 doi "https://doi.org/10.3760/cma.j.issn.1006-9801.2013.04.009" @default.
• W3032022111 hasPublicationYear "2013" @default.
• W3032022111 type Work @default.
• W3032022111 sameAs 3032022111 @default.
• W3032022111 citedByCount "0" @default.
• W3032022111 crossrefType "journal-article" @default.
• W3032022111 hasAuthorship W3032022111A5066415651 @default.
• W3032022111 hasConcept C126322002 @default.
• W3032022111 hasConcept C159110408 @default.
• W3032022111 hasConcept C159641895 @default.
• W3032022111 hasConcept C197934379 @default.
• W3032022111 hasConcept C205679159 @default.
• W3032022111 hasConcept C2779951463 @default.
• W3032022111 hasConcept C2780496750 @default.
• W3032022111 hasConcept C2780580376 @default.
• W3032022111 hasConcept C2780852908 @default.
• W3032022111 hasConcept C2781072394 @default.
• W3032022111 hasConcept C2781112942 @default.
• W3032022111 hasConcept C42219234 @default.
• W3032022111 hasConcept C71924100 @default.
• W3032022111 hasConcept C90924648 @default.
• W3032022111 hasConcept C98274493 @default.
• W3032022111 hasConceptScore W3032022111C126322002 @default.
• W3032022111 hasConceptScore W3032022111C159110408 @default.
• W3032022111 hasConceptScore W3032022111C159641895 @default.
• W3032022111 hasConceptScore W3032022111C197934379 @default.
• W3032022111 hasConceptScore W3032022111C205679159 @default.
• W3032022111 hasConceptScore W3032022111C2779951463 @default.
• W3032022111 hasConceptScore W3032022111C2780496750 @default.
• W3032022111 hasConceptScore W3032022111C2780580376 @default.
• W3032022111 hasConceptScore W3032022111C2780852908 @default.
• W3032022111 hasConceptScore W3032022111C2781072394 @default.
• W3032022111 hasConceptScore W3032022111C2781112942 @default.
• W3032022111 hasConceptScore W3032022111C42219234 @default.
• W3032022111 hasConceptScore W3032022111C71924100 @default.
• W3032022111 hasConceptScore W3032022111C90924648 @default.
• W3032022111 hasConceptScore W3032022111C98274493 @default.
• W3032022111 hasIssue "04" @default.
• W3032022111 hasLocation W30320221111 @default.
• W3032022111 hasOpenAccess W3032022111 @default.
• W3032022111 hasPrimaryLocation W30320221111 @default.
• W3032022111 hasRelatedWork W2348417715 @default.
• W3032022111 hasRelatedWork W2349413091 @default.
• W3032022111 hasRelatedWork W2352752108 @default.
• W3032022111 hasRelatedWork W2359857050 @default.
• W3032022111 hasRelatedWork W2360167430 @default.
• W3032022111 hasRelatedWork W2361711125 @default.
• W3032022111 hasRelatedWork W2365198035 @default.
• W3032022111 hasRelatedWork W2373379990 @default.
• W3032022111 hasRelatedWork W2377244559 @default.
• W3032022111 hasRelatedWork W2377731144 @default.
• W3032022111 hasRelatedWork W2378976817 @default.
• W3032022111 hasRelatedWork W2383263954 @default.
• W3032022111 hasRelatedWork W2383609661 @default.
• W3032022111 hasRelatedWork W2499465213 @default.
• W3032022111 hasRelatedWork W2800029275 @default.
• W3032022111 hasRelatedWork W2966927652 @default.
• W3032022111 hasRelatedWork W3030966008 @default.
• W3032022111 hasRelatedWork W3030968699 @default.
• W3032022111 hasRelatedWork W3032081736 @default.
• W3032022111 hasRelatedWork W3032186810 @default.
• W3032022111 hasVolume "25" @default.
• W3032022111 isParatext "false" @default.
• W3032022111 isRetracted "false" @default.
• W3032022111 magId "3032022111" @default.
• W3032022111 workType "article" @default.